IGC Pharma, Inc. (IGC) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $619.0K | -15.6% |
| 2024 | $733.0K | +65.8% |
| 2023 | $442.0K | +127.8% |
| 2022 | $194.0K | +71.7% |
| 2021 | $113.0K | -1.7% |
| 2020 | $115.0K | -12.9% |
| 2019 | $132.0K | +61.0% |
| 2018 | $82.0K | -62.4% |
| 2017 | $218.2K | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2025 | $619.0K | -15.6% |
| 2024 | $733.0K | +65.8% |
| 2023 | $442.0K | +127.8% |
| 2022 | $194.0K | +71.7% |
| 2021 | $113.0K | -1.7% |
| 2020 | $115.0K | -12.9% |
| 2019 | $132.0K | +61.0% |
| 2018 | $82.0K | -62.4% |
| 2017 | $218.2K | — |